Symbol="GRTS"
AssetType="Common Stock"
Name="Gritstone Oncology Inc"
Description="Gritstone bio, Inc., a clinical-stage biotechnology company, is dedicated to developing tumor-specific cancer immunotherapies to combat various types of cancer and infectious diseases. The company is headquartered in Emeryville, California."
CIK="1656634"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="5858 HORTON STREET, SUITE 210, EMERYVILLE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="173382000"
EBITDA="-119511000"
PERatio="None"
PEGRatio="None"
BookValue="1.604"
DividendPerShare="0"
DividendYield="0"
EPS="-1.19"
RevenuePerShareTTM="0.155"
ProfitMargin="0"
OperatingMarginTTM="-8.31"
ReturnOnAssetsTTM="-0.348"
ReturnOnEquityTTM="-0.756"
RevenueTTM="15197000"
GrossProfitTTM="-91458000"
DilutedEPSTTM="-1.19"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.66"
AnalystTargetPrice="8.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="15.92"
PriceToBookRatio="1.59"
EVToRevenue="12.36"
EVToEBITDA="-1.078"
Beta="0.522"
num_52WeekHigh="5.85"
num_52WeekLow="1.64"
num_50DayMovingAverage="2.094"
num_200DayMovingAverage="2.632"
SharesOutstanding="88914000"
DividendDate="None"
ExDividendDate="None"
symbol="GRTS"
open="1.94"
high="2.02"
low="1.93"
price="1.95"
volume="386122.00"
latest_trading_day="2023-07-28"
previous_close="1.91"
change="0.04"
change_percent="2.0942%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="94"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="6"
Volume_recent_avg="762171"
Change_recent_avg="-0.01"
Delta_recent_avg="0.18"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="-0.53"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_45"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="6"
Aroon_momentum_negative="94"
image_negative_thumbnail_id_1="109"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0067.jpeg"
image_negative_thumbnail_id_2="99"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0077.jpeg"
image_neutral_thumbnail_id_1="585"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_neutral_thumbnail_id_2="582"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0017.jpeg"
image_positive_thumbnail_id_1="649"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0059.jpeg"
image_positive_thumbnail_id_2="1010"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0172.jpeg"
image_professor_thumbnail_id_1="1187"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
